News

News

New Cognivia interview in Medical News Today on COVID-19 vaccines and ‘nocebo’ effect

New research suggests that a high percentage of reported side effects from COVID-19 vaccines may be due to what’s…

Read More
News

New Cognivia article in Applied Clinical Trials on “Using Machine Learning to Predict Placebo Response and Increase Clinical Trial Success”

The overall risk of clinical trial failure is still too high – meaning more repeat trials, lost timelines…

Read More
News

New Cognivia publication on the use of composite covariates to understand complex data in clinical trial data analysis

Covariates are typically used to control for factors that may impact the measurement of outcomes, particularly to describe individual patient characteristics that may or may not relate to treatment response. In fact, all patient baseline characteristics collected are potential covariates linked with the patient’s outcome.

Read More
News

Tools4Patient Announces Name Change to Cognivia & Expands Board of Directors

Mont-Saint-Guibert, Belgium, (Jan. 5, 2022 /PRNewswire) – Cognivia today announced a new name for the company formerly known as Tools4Patient,…

Read More
News

Tools4Patient becomes Cognivia

Friends, colleagues and Peers, Today we announce the change of our company name from Tools4Patient to Cognivia, to more closely…

Read More
News

Tools4Patient’s Placebell©™ Named One of the Most Innovative Products of 2021 by PM360

Mont-Saint-Guibert, Belgium (December 14, 2021): Tools4Patient‘s Placebell©™ was named one of the most innovative products of 2021 by PM360, a leading trade magazine…

Read More